Israel’s Lumenis Sells Surgical Operation for $1.1 Billion to Boston Scientific – Jewish Enterprise Information

Israel’s Lumenis Sells Surgical Operation for $1.1 Billion to Boston Scientific

Boston Scientific and Lumenis have had a enterprise relationship for 20 years now.

Boston Scientific has acquired the worldwide surgical enterprise of Israel’s Lumenis LTD. Lumenis is a privately-held firm that develops and commercializes energy-based medical options. The sale was for of $1.07 billion in money, topic to closing changes.

Baring Personal Fairness Asia (BPEA), Lumenis’ present proprietor, will retain management of the Lumenis world aesthetics and ophthalmology companies. With 2021 web gross sales anticipated to be roughly $200 million, the Lumenis surgical enterprise consists of premier laser methods, fibers and equipment used for urology and otolaryngology procedures. Foundational to its urology portfolio is the proprietary MOSES know-how, which has demonstrated differentiated scientific outcomes and effectivity within the administration of sufferers with kidney stones.

Lumenis is a worldwide chief within the discipline of minimally-invasive scientific options for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned professional in growing and commercializing modern energy-based applied sciences, together with Laser, Intense Pulsed Gentle (IPL) and Radio-Frequency (RF).

Lumenis LTD was based in 1966 and is headquartered in Yokneam, Israel. It has 1,500 staff together with 450 in Israel. Boston Scientific has had a relationship with Lumenis for greater than 20 years and at present sells the Lumenis urology laser portfolio within the U.S. and Japan by a distribution association. Upon completion of the acquisition, Boston Scientific will promote these lasers and fibers – in addition to the otolaryngology laser portfolio – to all geographies together with high-growth areas like China.


“We take nice delight in our heritage of innovation in surgical laser options that are serving to tens of millions of sufferers worldwide,” stated Tzipi Ozer-Armon, chief government officer, Lumenis. “Notably the proprietary, patent-protected MOSES know-how has revolutionized urology laser procedures by enhancing the scientific efficacy and effectivity for kidney stones. We’re assured that Boston Scientific, as a worldwide chief in urology, and our long-time business associate, is the perfect group to hold this legacy ahead.”

Boston Scientific transforms lives by modern medical options that enhance the well being of sufferers world wide. As a worldwide medical know-how chief for greater than 40 years, we advance science for all times by offering a broad vary of excessive efficiency options that tackle unmet affected person wants and scale back the price of healthcare


Learn extra about: Boston Scientific, Lumenis


Israel’s Lumenis Sells Surgical Operation for $1.1 Billion to Boston Scientific